Ascentage Pharma Group International Inc. (AAPG), a biopharmaceutical company, Monday announced the pricing of 22 million ordinary shares, par value $0.0001 per share, of the company, at a price of HKD68.60 per share for gross proceeds of about HKD1,509.2 million or approximately $192.3 million.
The offshore placement, which was oversubscribed by eight times, is expected to close on July 17, 2025.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.